Central Lab companies

Key Central Lab Market Players:

Below is the list of some prominent players operating in the global central lab market:

• IQVIA (U.S.)
• Labcorp Drug Development (U.S.)
• PPD Inc. (U.S.)
• Charles River Laboratories (U.S.)
• ICON plc (Ireland)
• Eurofins Scientific (Luxembourg)
• SGS SA (Switzerland)
• Intertek Group plc (UK)
• Unilabs (Switzerland)
• Cerba HealthCare (France)
• SRL Inc. (Japan)
• LSI Medience Corporation (Japan)
• Fujirebio (Japan)
• Sonic Healthcare (Australia)
• Healius Limited (Australia)
• Seegene Inc. (South Korea)
• Green Cross Laboratories (South Korea)
• Metropolis Healthcare Limited (India)
• Dr. Lal PathLabs (India)
• LabConnect (U.S.)
• Labor Dr. Wisplinghoff (U.S.)
• ARUP Laboratories (U.S.)
• Gribbles Pathology (Malaysia)
  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis

The central lab market is characterized by the presence of CROs, diagnostic laboratories, as well as testing service providers. Major players such as IQVIA, Labcorp Drug Development, and ICON plc dominate the market through extensive global laboratory networks and integrated clinical trial services. Pioneers in this field are making extensive investments in terms of automation, molecular technologies, and digital data platforms with a prime focus on improving efficiency and accuracy. Mergers and acquisitions, partnerships with pharmaceutical companies, and expansion into emerging markets are adopted by the players to strengthen service portfolios and enhance the overall geographic reach. In December 2024, Eurofins Central Laboratory announced the acquisition of Clinical Trial Pathology Services' assets from DCL Pathology LLC. This particular move strengthens Eurofins’ portfolio, particularly in terms of oncology and vaccine development, enhancing support for pharma, biotech, and CRO clients worldwide.

Corporate Landscape of the Central Lab Market:

• IQVIA is one of the leading players in the central lab market, which is offering integrated clinical research and laboratory services to pharmaceutical and biotechnology companies. The company benefits from its global laboratory network and improved analytics capabilities, which support highly complex clinical trials.
• Labcorp Drug Development is one of the most prominent central lab providers in the global landscape. Besides, the firm provides laboratory testing services for clinical trials, i.e., for biomarker testing, genomics, and companion diagnostics. LabCorp efficiently supports multinational trials with standardized processes and rapid turnaround times.
• PPD Inc., which operates as part of Thermo Fisher Scientific, provides laboratory testing, bioanalytical services, and biomarker analysis for clinical trials across multiple therapeutic areas. In addition, the firm has a strong international network of laboratories, which allows efficient handling of clinical samples and complex testing requirements.
• Eurofins Scientific is a major laboratory testing provider that has a huge network of laboratories across the globe. The company offers specialized testing services, which include central lab support for clinical trials, biomarker analysis, and bioanalytical testing.
• ICON plc is yet another prominent player in this field, which supports pharmaceutical, biotechnology, and medical device firms in terms of their laboratory testing, biomarker services, and sample management. ICON has strengthened its market position through acquisitions and strategic partnerships, enabling it to expand its service offerings and global reach.